Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Cognitive performance in patients with Mild Cognitive Impairment and Alzheimer's disease with white matter hyperintensities: An exploratory analysis.

Holz MR, Kochhann R, Ferreira P, Tarrasconi M, Chaves MLF, Fonseca RP.

Dement Neuropsychol. 2017 Oct-Dec;11(4):426-433. doi: 10.1590/1980-57642016dn11-040013.

2.

A continuum of executive function deficits in early subcortical vascular cognitive impairment: A systematic review and meta-analysis.

Sudo FK, Amado P, Alves GS, Laks J, Engelhardt E.

Dement Neuropsychol. 2017 Oct-Dec;11(4):371-380. doi: 10.1590/1980-57642016dn11-040006.

3.

Chilean version of the INECO Frontal Screening (IFS-Ch): psychometric properties and diagnostic accuracy.

Jory JI, Bruna AA, Muñoz-Neira C, Chonchol AS.

Dement Neuropsychol. 2013 Jan-Mar;7(1):40-47. doi: 10.1590/S1980-57642013DN70100007.

4.

Vascular dementia: Cognitive, functional and behavioral assessment. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Part II.

Engelhardt E, Tocquer C, André C, Moreira DM, Okamoto IH, Cavalcanti JLS; Working Group on Alzheimer’s Disease and Vascular Dementia of the Brazilian Academy of Neurology.

Dement Neuropsychol. 2011 Oct-Dec;5(4):264-274. doi: 10.1590/S1980-57642011DN05040004. Review.

5.

The Dementia Rating Scale (DRS) in the diagnosis of vascular dementia.

Porto CS, Caramelli P, Nitrini R.

Dement Neuropsychol. 2007 Jul-Sep;1(3):282-287. doi: 10.1590/S1980-57642008DN10300010.

6.

Large Perivascular Spaces Visible on Magnetic Resonance Imaging, Cerebral Small Vessel Disease Progression, and Risk of Dementia: The Age, Gene/Environment Susceptibility-Reykjavik Study.

Ding J, Sigurðsson S, Jónsson PV, Eiriksdottir G, Charidimou A, Lopez OL, van Buchem MA, Guðnason V, Launer LJ.

JAMA Neurol. 2017 Sep 1;74(9):1105-1112. doi: 10.1001/jamaneurol.2017.1397.

7.

Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT).

Weiner DE, Gaussoin SA, Nord J, Auchus AP, Chelune GJ, Chonchol M, Coker L, Haley WE, Killeen AA, Kimmel PL, Lerner AJ, Oparil S, Saklayen MG, Slinin YM, Wright CB, Williamson JD, Kurella Tamura M; SPRINT Study Research Group.

Am J Kidney Dis. 2017 Sep;70(3):357-367. doi: 10.1053/j.ajkd.2017.04.021. Epub 2017 Jun 9.

PMID:
28606731
8.

Neuropsychological Profiles Differentiate Alzheimer Disease from Subcortical Ischemic Vascular Dementia in an Autopsy-Defined Cohort.

Ramirez-Gomez L, Zheng L, Reed B, Kramer J, Mungas D, Zarow C, Vinters H, Ringman JM, Chui H.

Dement Geriatr Cogn Disord. 2017;44(1-2):1-11. doi: 10.1159/000477344. Epub 2017 Jun 9.

9.

Effects of Delay Duration on the WMS Logical Memory Performance of Older Adults with Probable Alzheimer's Disease, Probable Vascular Dementia, and Normal Cognition.

Montgomery V, Harris K, Stabler A, Lu LH.

Arch Clin Neuropsychol. 2017 May 1;32(3):375-380. doi: 10.1093/arclin/acx005.

PMID:
28431036
10.

Isometric Exercise Training for Managing Vascular Risk Factors in Mild Cognitive Impairment and Alzheimer's Disease.

Hess NC, Smart NA.

Front Aging Neurosci. 2017 Mar 3;9:48. doi: 10.3389/fnagi.2017.00048. eCollection 2017. Review.

11.

MRI-based comparative study of different mild cognitive impairment subtypes: protocol for an observational case-control study.

Yu Y, Zhao W, Li S, Yin C.

BMJ Open. 2017 Mar 8;7(3):e013432. doi: 10.1136/bmjopen-2016-013432.

12.

A T1 and DTI fused 3D corpus callosum analysis in MCI subjects with high and low cardiovascular risk profile.

Lao Y, Nguyen B, Tsao S, Gajawelli N, Law M, Chui H, Weiner M, Wang Y, Leporé N.

Neuroimage Clin. 2016 Dec 28;14:298-307. doi: 10.1016/j.nicl.2016.12.027. eCollection 2017.

13.

How does white matter microstructure differ between the vascular and amnestic mild cognitive impairment?

Yu Y, Liang X, Yu H, Zhao W, Lu Y, Huang Y, Yin C, Gong G, Han Y.

Oncotarget. 2017 Jan 3;8(1):42-50. doi: 10.18632/oncotarget.13960.

14.

Clinical usefulness of the clock drawing test applying rasch analysis in predicting of cognitive impairment.

Yoo DH, Lee JS.

J Phys Ther Sci. 2016 Jul;28(7):2140-3. doi: 10.1589/jpts.28.2140. Epub 2016 Jul 29.

15.

Changes in Neurocognitive Architecture in Patients with Obstructive Sleep Apnea Treated with Continuous Positive Airway Pressure.

Rosenzweig I, Glasser M, Crum WR, Kempton MJ, Milosevic M, McMillan A, Leschziner GD, Kumari V, Goadsby P, Simonds AK, Williams SC, Morrell MJ.

EBioMedicine. 2016 May;7:221-9. doi: 10.1016/j.ebiom.2016.03.020. Epub 2016 Mar 25.

16.

Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?

Van Dam D, Vermeiren Y, Dekker AD, Naudé PJ, Deyn PP.

Curr Alzheimer Res. 2016;13(10):1145-64. Review.

17.

Demographic Features and Neuropsychological Correlates in a Cohort of 200 Patients with Vascular Cognitive Decline Due to Cerebral Small Vessel Disease.

Issac TG, Chandra SR, Rajeswaran J, Christopher R, Philip M.

Indian J Psychol Med. 2016 Mar-Apr;38(2):127-32. doi: 10.4103/0253-7176.178778.

18.

Association of Ideal Cardiovascular Health With Vascular Brain Injury and Incident Dementia.

Pase MP, Beiser A, Enserro D, Xanthakis V, Aparicio H, Satizabal CL, Himali JJ, Kase CS, Vasan RS, DeCarli C, Seshadri S.

Stroke. 2016 May;47(5):1201-6. doi: 10.1161/STROKEAHA.115.012608. Epub 2016 Apr 12.

19.

Hippocampal subfield volumetry in patients with subcortical vascular mild cognitive impairment.

Li X, Li D, Li Q, Li Y, Li K, Li S, Han Y.

Sci Rep. 2016 Feb 15;6:20873. doi: 10.1038/srep20873.

20.

Vascular Factors and Cognitive Dysfunction in Alzheimer Disease.

Pąchalska M, Bidzan L, Bidzan M, Góral-Półrola J.

Med Sci Monit. 2015 Nov 12;21:3483-9.

Supplemental Content

Support Center